Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V P Werth

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Parvovirus b19 infection associated with acute hepatitis, arthralgias, and rashJ M Weinberg, J T Wolfe, A L Frattali, et al.
The British Journal of Dermatology|December 14, 2020
Establishing cut-off values for mild, moderate and severe disease in patients with pemphigus using the Pemphigus Disease Area IndexR L Krain, C E Bax, S Chakka, et al.
The British Journal of Dermatology|June 14, 2016
Clinical signs associated with an increased risk of interstitial lung disease: a retrospective study of 101 patients with dermatomyositisC C Ang, C O Anyanwu, E Robinson, et al.
Annals of Internal Medicine|May 15, 1990
L-tryptophan ingestion associated with eosinophilic fasciitis but not progressive systemic sclerosisB Freundlich, V P Werth, A H Rook, et al.
Lupus Science & Medicine|April 11, 2015
Redefining cutaneous lupus erythematosus: a proposed international consensus approach and results of a preliminary questionnaireJ F Merola, F Nyberg, F Furukawa, et al.
The British Journal of Dermatology|May 22, 2015
Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical changeC O Anyanwu, D F Fiorentino, L Chung, et al.
The British Journal of Dermatology|October 22, 2020
Identifying the required degree of disease clearance to improve quality of life in pemphigus vulgarisC E Bax, A Ravishankar, D Yan, et al.
Clinical and Experimental Rheumatology|February 10, 2006
Skin involvement and outcome measures in systemic autoimmune diseasesJ Albrecht, F Atzeni, C Baldini, et al.
The British Journal of Dermatology|June 20, 2012
A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosusR Vasquez, D Wang, Q P Tran, et al.
The British Journal of Dermatology|February 16, 2019
Practice-based differences in paediatric discoid lupus erythematosusL M Arkin, K Buhr, H Brandling-Bennett, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Parvovirus b19 infection associated with acute hepatitis, arthralgias, and rashJ M Weinberg, J T Wolfe, A L Frattali, et al.
The British Journal of Dermatology|December 14, 2020
Establishing cut-off values for mild, moderate and severe disease in patients with pemphigus using the Pemphigus Disease Area IndexR L Krain, C E Bax, S Chakka, et al.
The British Journal of Dermatology|June 14, 2016
Clinical signs associated with an increased risk of interstitial lung disease: a retrospective study of 101 patients with dermatomyositisC C Ang, C O Anyanwu, E Robinson, et al.
Annals of Internal Medicine|May 15, 1990
L-tryptophan ingestion associated with eosinophilic fasciitis but not progressive systemic sclerosisB Freundlich, V P Werth, A H Rook, et al.
Lupus Science & Medicine|April 11, 2015
Redefining cutaneous lupus erythematosus: a proposed international consensus approach and results of a preliminary questionnaireJ F Merola, F Nyberg, F Furukawa, et al.
The British Journal of Dermatology|May 22, 2015
Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical changeC O Anyanwu, D F Fiorentino, L Chung, et al.
The British Journal of Dermatology|October 22, 2020
Identifying the required degree of disease clearance to improve quality of life in pemphigus vulgarisC E Bax, A Ravishankar, D Yan, et al.
Clinical and Experimental Rheumatology|February 10, 2006
Skin involvement and outcome measures in systemic autoimmune diseasesJ Albrecht, F Atzeni, C Baldini, et al.
The British Journal of Dermatology|June 20, 2012
A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosusR Vasquez, D Wang, Q P Tran, et al.
The British Journal of Dermatology|February 16, 2019
Practice-based differences in paediatric discoid lupus erythematosusL M Arkin, K Buhr, H Brandling-Bennett, et al.
Pageof 10